Haemonetics Corporation (HAE)
NYSE: HAE
· Real-Time Price · USD
68.92
0.91 (1.34%)
At close: May 09, 2025, 11:40 AM
Haemonetics Revenue Breakdown
| Period Ending | Sep 28, 2024 | Apr 3, 2021 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Sep 27, 2014 | Jun 28, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Blood Center Revenue | 68.8M | 72.92M | 67.16M | 68.24M | 64.48M | 73.4M | 74.23M | 71.71M | 65.56M | 82.32M | 76.35M | 74.27M | 70.94M | 83.28M | 86.37M |
| Blood Center Revenue Growth | -5.65% | +8.59% | -1.59% | +5.83% | -12.15% | -1.11% | +3.51% | +9.37% | -20.36% | +7.82% | +2.81% | +4.69% | -14.82% | -3.57% | n/a |
| Hospital Revenue | 138.38M | 83.75M | 48.38M | 48.99M | 47.96M | 111.58M | 113.1M | 109.77M | 101.51M | 100.86M | 108.66M | 103.56M | 97.65M | 30.61M | 30.6M |
| Hospital Revenue Growth | +65.24% | +73.11% | -1.24% | +2.14% | -57.02% | -1.34% | +3.03% | +8.14% | +0.64% | -7.18% | +4.92% | +6.06% | +219.05% | +0.02% | n/a |
| Plasma Revenue | 138.56M | n/a | 131.82M | 124.35M | 116.9M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Plasma Revenue Growth | n/a | n/a | +6.01% | +6.37% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Mar 30, 2024 | Apr 1, 2023 | Apr 2, 2022 | Apr 3, 2021 | Mar 28, 2020 | Mar 30, 2019 | Mar 31, 2018 | Apr 1, 2017 | Apr 2, 2016 | Mar 28, 2015 | Mar 29, 2014 | Mar 30, 2013 | Mar 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Revenue | 107.54M | 104.14M | 110.8M | 105.82M | 109.3M | 118.7M | 115.13M | 109.86M | 111.76M | 88.3M | 108.68M | 120.73M | 124.38M |
| Asia Revenue Growth | +3.27% | -6.02% | +4.71% | -3.18% | -7.92% | +3.10% | +4.80% | -1.70% | +26.57% | -18.75% | -9.98% | -2.94% | n/a |
| Europe Revenue | 160.14M | 156.68M | 163.52M | 159.08M | 153.35M | 164.5M | 164.23M | 166.01M | 187.72M | 494.79M | 500.72M | 454.87M | 352.16M |
| Europe Revenue Growth | +2.21% | -4.18% | +2.79% | +3.74% | -6.78% | +0.17% | -1.07% | -11.57% | -62.06% | -1.18% | +10.08% | +29.17% | n/a |
| Japan Revenue | 58.09M | 61.3M | 75.56M | 77.68M | 72.22M | 69.91M | 67.32M | 79.27M | 81.41M | n/a | n/a | n/a | n/a |
| Japan Revenue Growth | -5.23% | -18.88% | -2.72% | +7.56% | +3.30% | +3.85% | -15.07% | -2.63% | n/a | n/a | n/a | n/a | n/a |
| Other Country Or Region Revenue | 13.28M | 3.65M | 3.99M | 5.28M | 7.42M | 7.62M | 8.52M | 8.3M | 8.5M | n/a | n/a | n/a | n/a |
| Other Country Or Region Revenue Growth | +263.62% | -8.45% | -24.47% | -28.75% | -2.72% | -10.54% | +2.66% | -2.34% | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 970.01M | 842.9M | 639.32M | 522.61M | 646.2M | 606.85M | 548.73M | 522.69M | 519.44M | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +15.08% | +31.84% | +22.33% | -19.13% | +6.49% | +10.59% | +4.98% | +0.62% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Dec 26, 2020 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Apr 2, 2016 | Dec 26, 2015 | Sep 26, 2015 | Jun 27, 2015 | Mar 28, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 106.46M | 106.95M | 107.98M | 106.44M | 111.71M | 104.9M | 93.48M | 97.38M | 94.66M | 92.41M | 92.23M | 91.84M | 80.73M | 75.78M | 91.22M | 83.71M | 73.45M | 71.7M | 69.54M | 78.57M | 78.27M | 69.84M | 73M | 78.61M | 73.88M | 77.25M | 68.55M | 79.02M | 97.86M | 72.78M | 66.86M | 73.09M | 70.96M | 71.12M | 87.5M | 83.02M | 78.94M | 74.56M | 87.61M | 79.6M |
| Selling, General, and Administrative Revenue Growth | -0.46% | -0.96% | +1.45% | -4.72% | +6.49% | +12.21% | -4.00% | +2.87% | +2.43% | +0.20% | +0.42% | +13.77% | +6.53% | -16.93% | +8.97% | +13.98% | +2.44% | +3.11% | -11.50% | +0.39% | +12.07% | -4.33% | -7.13% | +6.40% | -4.36% | +12.70% | -13.26% | -19.24% | +34.45% | +8.86% | -8.52% | +3.00% | -0.23% | -18.72% | +5.39% | +5.17% | +5.87% | -14.89% | +10.06% | n/a |
| Research and Development Revenue | 15.83M | 16.53M | 14.46M | 13.99M | 13.27M | 12.66M | 12.65M | 15.64M | 12.69M | 10.9M | 10.9M | 13.21M | 10.04M | 10.85M | 12.7M | 10.84M | 7.5M | 6.76M | 7.75M | 8.97M | 7M | 7.42M | 7.49M | 8.75M | 8.98M | 8.58M | 9.41M | 11.09M | 12.43M | 7.52M | 8.19M | 9.32M | 8.46M | 8.34M | 11.44M | 11.75M | 10.94M | 11.55M | 11.32M | 17.23M |
| Research and Development Revenue Growth | -4.24% | +14.31% | +3.34% | +5.50% | +4.74% | +0.13% | -19.15% | +23.29% | +16.46% | -0.06% | -17.47% | +31.61% | -7.52% | -14.55% | +17.14% | +44.55% | +10.91% | -12.74% | -13.64% | +28.20% | -5.69% | -0.87% | -14.40% | -2.57% | +4.60% | -8.75% | -15.16% | -10.78% | +65.23% | -8.20% | -12.10% | +10.15% | +1.51% | -27.11% | -2.66% | +7.38% | -5.29% | +2.05% | -34.28% | n/a |